# Rapid Medical Diagnostic Kits Market and Forecast 2025-2033

Limited-Time Offer \[Flat 15% Discount\] [Dismiss](#)

[Skip to content](#content "Skip to content")

[Updated Data Matrix Available](https://www.ihealthcareanalyst.com/research-services/)

Market Value | Market Volume | Epidemiology | Clinical Trials | Patent Landscape | Regulatory Approvals

[Home](https://www.ihealthcareanalyst.com/) » [Reports](https://www.ihealthcareanalyst.com/shop/) » [Clinical Diagnostics](https://www.ihealthcareanalyst.com/reports/clinical-diagnostics/amp/)

![Awaiting product image](data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7)

![Awaiting product image](https://www.ihealthcareanalyst.com/wp-content/uploads/2019/08/report-icon4-e1565791186498.png)

# Rapid Medical Diagnostic Kits Market by Technology (Flow-Through Assays, Lateral Flow Immunoassays, Latex agglutination Assays, Solid-Phase Assays), Application \[Blood Glucose Testing, Lipid Profile (Cholesterol) Testing, Fertility & Pregnancy Testing, Infectious Disease Testing (Hepatitis, HIV, Influenza, COVID-19, Tuberculosis, Others (Gastrointestinal, Meningitis, Encephalitis), Substance Abuse / Toxicity Testing, Others\], End User (Hospitals & Clinics, Diagnostic Laboratories, Home Use) and Forecast 2025-2033

$3,000.00

## Report Specifications: Market Size, Market Share, Growth Trends, Forecast, Geography

Rapid Medical Diagnostic Tests (RDTs) are diagnostic assays designed for use at the point-of-care (POC) and can be adapted for use in low-resource settings. An RDT is low-cost, simple to operate and read, sensitive, specific, stable at high temperatures, and works in a short period of time.

Rapidly growing medical diagnostics industry, higher demand for preventive management of infectious diseases caused by virus and bacteria worldwide are some of the factors contributing to the growth of global rapid medical diagnostic testing kits market. Rapid medical diagnostics is used for detection of various infectious diseases, caused diabetes, measuring cholesterol levels, testing drug abuse and pregnancy testing.

The global rapid medical diagnostic kits market report estimates the market size ($million 2023 to 2033) for market segmentation based on technology (flow-through assays, lateral flow immunoassays, latex agglutination assays, solid-phase assays); by application \[blood glucose testing, lipid profile (cholesterol) monitoring, infectious disease testing (hepatitis, HIV, influenza, COVID-19, tuberculosis, others), fertility and pregnancy testing, substance of abuse / toxicity testing\]; by end user \[hospitals and clinics, diagnostic laboratories, home use), and forecast (CAGR%, 2025 to 2033).

The global rapid medical diagnostic kits market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

The global rapid medical diagnostic kits market report also provides the detailed market landscape, market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments.

Major players operating in the global rapid medical diagnostic kits market and included in this report are Abaxis, Inc., Abbott Laboratories, Inc., ACON Laboratories, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., bioMérieux SA, Cardinal Health, Danaher Corporation (Beckman Coulter), Meridian Bioscience, Inc., Roche Holding AG (F. Hoffmann La Roche AG), and Trinity Biotech plc.

**DATA INCLUDED:** Rapid Medical Diagnostic Kits Market Size, Rapid Medical Diagnostic Kits Market Share, Rapid Medical Diagnostic Kits Market Growth Rates, Rapid Medical Diagnostic Kits Market Trends, and Rapid Medical Diagnostic Kits Market Forecast to 2033

**Market Data:**

*   Estimation Base Year: 2024
*   Historical Data Range: 2023-2024
*   Forecast Period: 2025-2033
*   Market Representation: Revenue in $million and CAGR % from 2025 to 2033
*   Regional Scope: North America, Europe, Asia Pacific, Latin America, Rest of the World (Middle East & Africa)
*   Country Scope: U.S., Canada, U.K., Germany, France, Italy, Spain, Japan, China, India, South Korea, Brazil, Mexico, South Africa, South Korea, Saudi Arabia, UAE, and other countries.
*   Report Coverage: Revenue forecasts, company market share, competitive landscape analysis, growth factors, and market trends
*   Customization Scope (15% Free): Accommodation of specific or custom requirements beyond the current report scope.

**Qualitative Analysis:**

*   Industry Overview
*   Industry Trends
*   Market Driver, Restraints, and Opportunities
*   Market Size
*   Growth Trends
*   Porter’s Five Forces Analysis
*   Market Attractiveness Matrix
*   Competitive Landscape
    *   Company Overview
    *   Financial Performance
    *   Product Portfolio
    *   Strategic Insights
    *   Recent Developments

**Quantitative Analysis:**

*   Market Size Projections: Comprehensive estimates and forecasts for all segments
*   Regional Market Analysis: Estimates and forecasts for key countries
*   Corporate Financial Performance: Analysis of company financials
*   Competitive Landscape: Market share analysis of leading companies

Choose License Type

Choose an optionSingle-user LicenseMulti-user LicenseCorporate License[Clear](#)

Rapid Medical Diagnostic Kits Market by Technology (Flow-Through Assays, Lateral Flow Immunoassays, Latex agglutination Assays, Solid-Phase Assays), Application \[Blood Glucose Testing, Lipid Profile (Cholesterol) Testing, Fertility & Pregnancy Testing, Infectious Disease Testing (Hepatitis, HIV, Influenza, COVID-19, Tuberculosis, Others (Gastrointestinal, Meningitis, Encephalitis), Substance Abuse / Toxicity Testing, Others\], End User (Hospitals & Clinics, Diagnostic Laboratories, Home Use) and Forecast 2025-2033 quantity 

Buy Report   

For inquiries regarding discounts on single or bundled report purchases, please reach out to us.

*   [Table of Contents CD](#tab-table-of-contents-cd)
*   [Market Segments and Companies](#tab-market-segments-and-companies)
*   [Request ToC / Sample](#tab-request-toc-sample-discount)

1.  **Introduction**
2.  **Executive Summary**
    *   Market Size Estimation ($million, 2023-2033)
    *   Forecast Estimation ($million and CAGR%, 2025-2033)
3.  [**Research Methodology**](https://www.ihealthcareanalyst.com/research-methodology/)
4.  **Market Landscape**
    *   Market Dynamics
        *   Drivers
        *   Barriers
        *   Opportunities
    *   Market Share Analysis
        *   Companies
        *   Products
    *   Market Trends Analysis
        *   Key success factors
        *   Market Growth Rate
    *   Market Attractiveness Analysis
    *   Market Profitability Analysis
        *   Buyer power
        *   Supplier power
        *   Barriers to entry
        *   Threat of substitute products
        *   Rivalry among firms in the industry
    *   Distribution Channels
5.  **Market Segmentation** \[_refer Market Segments and Companies Tab_\]
    *   Diagnostic Test Type
    *   Indication or Infection Type
    *   Technology
    *   Diagnostics Application
    *   Service Type
    *   End User Groups
6.  **Geography (Region, Country)**
    *   North America (U.S., Canada)
    *   Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    *   Asia Pacific (Japan, China, India, Rest of APAC)
    *   Latin America (Brazil, Mexico, Rest of LA)
    *   Rest of the World (Middle East & Africa)
7.  **Regulatory Overview** 
    *   Device Classification I, II, III, IV
    *   Device (FDA, EMEA) Approvals
8.  **Company Profiles** \[_refer Market Segments and Companies Tab_\]
    *   Company Overview
    *   Financial Snapshot
    *   Product Portfolio
    *   Business Strategies
    *   Recent Developments
9.  **Recommendations**
10.  **References**

**Key Questions Answered:**  
1\. What are the factors driving and limiting this market, key success factors and challenges?  
2\. Which are the leading competitors in the market, their market share, profitability and key trends by product, technology, services portfolio?  
3\. How do markets perform between countries and regions?  
4\. What market segments are contributing to maximum share and greatest growth?  
5\. What is the product or procedure volumes by country and regions?

**Actionable Insights Included:**  
1\. Product portfolio matrix (Share vs. Growth)  
2\. Market attractiveness (Region vs. Growth)  
3\. Spot matrix (Product vs. Region)  
4\. Geographic distribution matrix (Share vs. Growth)

**Rapid Diagnostic Testing (RDT) Kits Market**

1\. **Technology**  
1.1. Flow-Through Assays  
1.2. Lateral Flow Immunoassays  
1.3. Latex agglutination Assays  
1.4. Solid-Phase Assays

2\. **Application**  
2.1. Blood Glucose Testing  
2.2. Lipid Profile (Cholesterol) Testing  
2.3. Fertility & Pregnancy Testing  
2.4. Infectious Disease Testing  
2.4.1. Hepatitis  
2.4.2. HIV  
2.4.3. Influenza  
2.4.4. COVID-19  
2.4.5. Tuberculosis  
2.4.6. Others (Gastrointestinal, Meningitis, Encephalitis)  
2.5. Substance Abuse / Toxicity Testing  
2.6. Others

3\. **End User**  
3.1. Hospitals & Clinics  
3.2. Diagnostic Laboratories  
3.3. Home Use

4\. **Geography**  
4.1. North America (U.S., Canada)  
4.2. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)  
4.3. Asia Pacific (Japan, China, India, Rest of APAC)  
4.4. Latin America (Brazil, Mexico, Rest of LA)  
Rest of the World

5\. **Company Profiles**  
5.1. Abaxis, Inc.  
5.2. Abbott Laboratories, Inc.  
5.3. ACON Laboratories, Inc.  
5.4. Becton, Dickinson and Company  
5.5. Bio-Rad Laboratories, Inc.  
5.6. bioMérieux SA  
5.7. Cardinal Health  
5.8. Danaher Corporation (Beckman Coulter)  
5.9. Meridian Bioscience, Inc.  
5.10. Roche Holding AG (F. Hoffmann La Roche AG)  
5.11. Trinity Biotech plc

**Request Table of Contents / Sample Report**

Full Name\*

Company Email\*

Phone Number\* \[Please add country code\]

Subject\*

Message\*

Resource Links

*   [About Us](https://www.ihealthcareanalyst.com/about/)
*   [Clinical Trials](https://www.ihealthcareanalyst.com/clinical-trials-dashboard/)
*   [Drugs@FDA](https://www.ihealthcareanalyst.com/drugs-fda-dashboard/)
*   [Orange Book](https://www.ihealthcareanalyst.com/orange-book-dashboard/)
*   [Premarket Approval](https://www.ihealthcareanalyst.com/premarket-approval-pma/)
*   [Premarket Notification](https://www.ihealthcareanalyst.com/premarket-notification-510k/)
*   [Publications](https://www.ihealthcareanalyst.com/publications/)

Terms and Conditions

*   [FAQs](https://www.ihealthcareanalyst.com/faqs/)
*   [Careers](https://www.ihealthcareanalyst.com/careers/)
*   [Terms of Use](https://www.ihealthcareanalyst.com/terms/)
*   [How to Order](https://www.ihealthcareanalyst.com/order/)
*   [Return Policy](https://www.ihealthcareanalyst.com/return/)
*   [Privacy Policy](https://www.ihealthcareanalyst.com/privacy/)
*   [Disclaimer Policy](https://www.ihealthcareanalyst.com/disclaimer/)

Secure Online Payment

![iHealthcareAnalyst, Inc.](https://www.ihealthcareanalyst.com/wp-content/uploads/2018/07/creditcard-payment-logos-300x48.jpg)

Search

Search

Contact Address

**US Office:** 2109, Mckelvey Hill Drive, Maryland Heights, MO 63043, United States  
Phone: +1 (314) 315-4764  
**India Office:** 5, Shilpa Chambers, Opp. J. M. Road, Shivajinager, Pune 411005, India  
Phone: +91 (20) 25898524  
Email: [\[email protected\]](/cdn-cgi/l/email-protection#2c5f4d40495f6c4544494d4058444f4d5e494d424d40555f58024f4341)

[](# "Scroll back to top")

Search for: